Skip to Main Content

Paper Details

Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer.
J Pathol
51
2012
C15orf21, MSI2, MYC, exome, genome, hybrid, hybrid luminal-neuroendocrine, hybrid luminal-neuroendocrine tumour, luminal and neuroendocrine cell types, prostate adenocarcinoma, prostate cancer, prostate tumour, stem cell gene, stem cell gene MSI2, tumour
Adenocarcinoma, Combined Modality Therapy, DNA, Neoplasm, Gene Amplification, Gene Dosage, Gene Expression Profiling, Gene Expression Regulation, Neoplastic, Gene Fusion, Genomics, Humans, Male, Middle Aged, Neuroendocrine Cells, Prognosis, Prostatectomy, Prostatic Neoplasms, RNA-Binding Proteins, Sequence Analysis, DNA, Sequence Analysis, RNA
Author NameAffiliation
Chunxiao WuUniversity of British Columbia
  • 1 - 1

Datasets

Release 1.2